13-109179569-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001198950.3(MYO16):​c.5351G>A​(p.Arg1784Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000948 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000086 ( 0 hom. )

Consequence

MYO16
NM_001198950.3 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.670
Variant links:
Genes affected
MYO16 (HGNC:29822): (myosin XVI) This gene encodes an unconventional myosin protein. The encoded protein has been proposed to act as a serine/threonine phosphatase-1 targeting or regulatory subunit. Studies in a rat cell line suggest that this protein may regulate cell cycle progression. A variant within this gene may be associated with susceptibility to schizophrenia and elevated expression of this gene has been observed in the frontal cortex of human schizophrenia patients. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.023658454).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO16NM_001198950.3 linkuse as main transcriptc.5351G>A p.Arg1784Gln missense_variant 34/35 ENST00000457511.7 NP_001185879.1 F8W883

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO16ENST00000457511.7 linkuse as main transcriptc.5351G>A p.Arg1784Gln missense_variant 34/351 NM_001198950.3 ENSP00000401633.3 F8W883
MYO16ENST00000356711.7 linkuse as main transcriptc.5285G>A p.Arg1762Gln missense_variant 34/351 ENSP00000349145.2 Q9Y6X6-1
MYO16-AS1ENST00000439299.1 linkuse as main transcriptn.30-12265C>T intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152184
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000135
AC:
34
AN:
251460
Hom.:
0
AF XY:
0.000132
AC XY:
18
AN XY:
135904
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000105
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000862
AC:
126
AN:
1461590
Hom.:
0
Cov.:
30
AF XY:
0.0000784
AC XY:
57
AN XY:
727102
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000827
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152302
Hom.:
0
Cov.:
33
AF XY:
0.000175
AC XY:
13
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.0000842
Hom.:
0
Bravo
AF:
0.000246
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 12, 2024The c.5351G>A (p.R1784Q) alteration is located in exon 34 (coding exon 34) of the MYO16 gene. This alteration results from a G to A substitution at nucleotide position 5351, causing the arginine (R) at amino acid position 1784 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
12
DANN
Benign
0.91
DEOGEN2
Benign
0.0092
T;T;T
Eigen
Benign
-0.81
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.083
N
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.024
T;T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
2.0
M;.;M
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.5
N;.;N
REVEL
Benign
0.21
Sift
Uncertain
0.0040
D;.;D
Sift4G
Uncertain
0.0050
D;D;D
Polyphen
0.91
P;.;P
Vest4
0.13
MVP
0.46
MPC
0.84
ClinPred
0.029
T
GERP RS
1.1
Varity_R
0.066
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs188457804; hg19: chr13-109831917; COSMIC: COSV62748351; API